New ACO model for dual-eligible beneficiaries announced by CMS

CMS has announced the creation of the Medicare-Medicaid Accountable Care Organization (ACO) model, aiming to improve care coordination for beneficiaries who are enrolled in both programs.

In current CMS models, like the Medicare Shared Savings Program, dual-eligible beneficiaries can be attributed to ACOs, but often don’t have financial accountability for their Medicaid expenditures. The new model will allow ACOs to be accountable for both Medicare and Medicaid costs for this population’s care.

“This model aims to provide improved care coordination for those enrolled in both Medicare and Medicaid, allowing providers to focus more on providing care for their patients rather than administrative work,” said Patrick Conway, MD, CMS acting principal deputy administrator and chief medical officer. “CMS continues to partner with and leverage the best ideas from states to transform our health care system to improve quality and care coordination. In the long run, this partnership will result in healthier people and smarter spending.”

The first step to implementing the model is asking states to submit letters of intent to CMS. Up to six states will be chosen and then applications will be accepted from ACOs and provider in those states.

States will be able to choose when the first performance period begins, opting to start in 2018, 2019 or 2020. For those which want to jump in as soon as possible, letters of intent will be due by Jan. 20, 2017.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.